Jun 04, 2020
Evolugate Takes Up the Challenge of Boosting Host Cells Used to Manufacture COVID-19 Vaccines
May 14, 2020
Colorcon, Inc. Launches SoteriaRx(TM) On-Dose Authentication Technology Platform
Apr 28, 2020
Moleculin Approved to Accelerate European Clinical Trial
Mar 17, 2020
Major Pharmaceutical Company Selects Wellness BioSciences Rx As Exclusive Distributor for New CBD Product Category
Mar 03, 2020
PLT to Launch Zynamite® PX for Sports Nutrition
Feb 18, 2020
Global Autoinjector Market (3rd Edition), 2020-2030
Dec 17, 2019
NeoMed Awarded US Patent for ENFit® Low Dose Tip Syringe
Dec 03, 2019
PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook (2019 Edition) - ResearchAndMarkets.com
Nov 11, 2019
Indalo Therapeutics Presents Phase 1 Clinical Trial Results for Lead Antifibrotic Drug Candidate IDL-2965
Sep 25, 2019
89bio Announces Dosing of First Patients in NASH Study and Issuance of Composition of Matter Patent
Sep 13, 2019
Positive Results Announced From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Halozyme's Enhanze® Drug Delivery Technology
Sep 05, 2019
Immunic, Inc.'s Interim Dosing Analysis of IMU-838 as Part of its Ongoing Phase 2 CALDOSE-1 Study in Patients with Moderate-to-Severe Ulcerative Colitis Establishes Broad, Potentially Safe and Effective Dose Range
Jun 20, 2019
Syqe Medical Receives Regulatory Approval to Release World's First Drug Delivery Device for Precise Dosing of Cannabis
Jun 18, 2019
DURECT Announces Completion of the 90 mg Severe Cohort and Dose Escalation Committee Approval to Commence 150 mg Dosing in Patients with Severe Alcoholic Hepatitis (AH) in its Ongoing DUR-928 Phase 2a AH Trial
May 05, 2019
Casa Verde Invests in Indose, the World's First Metered Dosage Vaporizer Technology
Apr 16, 2019
Rapid Dose Therapeutics and TFB & Associates Ltd. Sign Agreement for the Sale and Distribution of Innovative Quickstrip(TM) Nutraceutical Product Line Across Canada
Apr 09, 2019
Enesi Pharma and University of Oxford Collaborate to Target Plague With a Novel ImplaVax®-enabled Adenovirus-based Solid Dose Vaccine
Mar 27, 2019
DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with Non-Alcoholic Steatohepatitis (NASH)
Mar 19, 2019
Merchavia Announces First Investment Agreement in the Medical Cannabis Sector
Jan 11, 2019
ForeverGreen Revolutionizes Top Selling Product KetonX With the Added Health Benefits of CBD Oil